Fostemsavir Tris (Synonyms: BMS-663068 Tris) |
Catalog No.GC36072 |
Le fostemsavir Tris (BMS-663068 (Tris)) est le promédicament phosphonooxyméthyle du BMS-626529.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 864953-39-9
Sample solution is provided at 25 µL, 10mM.
Fostemsavir Tris (BMS-663068 (Tris)) is the phosphonooxymethyl prodrug of BMS-626529. Fostemsavir Tris (BMS-663068 (Tris)) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells. HIV-1[1]
Fostemsavir Tris has good antiviral activity in subjects infected with virus shown to be susceptible (IC50, <100 nM) to the agent[1].
[1]. Nowicka-Sans B, et al. In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068. Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507.
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *